Patents by Inventor Menashe Terem

Menashe Terem has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200260998
    Abstract: A wearable motion monitoring device including: a housing sized and shaped to be positioned between a body region of a subject and a garment worn by the patient; a marker included in said housing, said marker including at least one light emitter, wherein said light emitter is positioned to emit light from an upper surface of said marker, such that said at least one light emitter is indicative of displacements of said body region; at least one garment holder incorporated in said housing, said holder serves as an anchoring point between said marker and said garment, said garment overlies said marker when anchored by said at least one garment holder.
    Type: Application
    Filed: September 5, 2018
    Publication date: August 20, 2020
    Applicant: BreatheVision Latd.
    Inventors: Ditza AUERBACH, Menashe TEREM
  • Patent number: 8097433
    Abstract: The present invention provides a non-toxic diagnostic composition for intravaginal monitoring of vaginal infections. The present invention further provides a diagnostic article for intravaginal monitoring of vaginal infections with the article including an absorbent material for absorbing vaginal secretions and a composition suitable for identification of the pH or the buffer capacities associated with vaginal secretions. The diagnostic composition provides a visible indication of vaginal infections, such as bacterial vaginosis.
    Type: Grant
    Filed: November 22, 2005
    Date of Patent: January 17, 2012
    Assignee: Common Sense, Ltd.
    Inventors: David Brusilovsky, Hadar Kessary-Shoam, Menashe Terem
  • Publication number: 20120003685
    Abstract: The present invention provides a non-toxic diagnostic composition for intravaginal monitoring of vaginal infections. The present invention further provides a diagnostic article for intravaginal monitoring of vaginal infections with the article including an absorbent material for absorbing vaginal secretions and a composition suitable for identification of the pH or the buffer capacities associated with vaginal secretions. The diagnostic composition provides a visible indication of vaginal infections, such as bacterial vaginosis.
    Type: Application
    Filed: April 13, 2011
    Publication date: January 5, 2012
    Inventors: Amnon Kritzman, Nitsa G. Nachshon, Yael Behar, David Brusilovsky, Menashe Terem, Adva Brand
  • Patent number: 7947467
    Abstract: A method for identifying physiological conditions associated with the pH or the buffer capacities of biological fluid secreted from a person, by providing a secretion-monitoring article of a body that includes an absorbent material for absorbing a biological fluid secreted from a person and an indicator system having a hydrophobic chemical composition that includes an indicator agent and an ion-balance reagent, at specific relative amounts. Optionally, a competitive agent for establishing a pre-set threshold of an analyte of interest in a tested bodily fluid, is added to the indicator system, wherein the indicator reagent being charged oppositely to the analyte of interest and the competitive reagent having the same charge as the indicator reagent.
    Type: Grant
    Filed: May 27, 2009
    Date of Patent: May 24, 2011
    Assignee: Common Sense Ltd.
    Inventors: Amnon Kritzman, Nitsa G. Nachshon, Yael Behar, David Brusilovsky, Menashe Terem, Adva Brand
  • Publication number: 20100136707
    Abstract: A method for identifying physiological conditions associated with the pH or the buffer capacities of biological fluid secreted from a person, by providing a secretion-monitoring article of a body that includes an absorbent material for absorbing a biological fluid secreted from a person and an indicator system having a hydrophobic chemical composition that includes an indicator agent and an ion-balance reagent, at specific relative amounts. Optionally, a competitive agent for establishing a pre-set threshold of an analyte of interest in a tested bodily fluid, is added to the indicator system, wherein the indicator reagent being charged oppositely to the analyte of interest and the competitive reagent having the same charge as the indicator reagent.
    Type: Application
    Filed: May 27, 2009
    Publication date: June 3, 2010
    Inventors: Amnon Kritzman, Nitsa G. Nachshon, Yael Behar, David Brusilovsky, Menashe Terem, Adva Brand
  • Publication number: 20090275071
    Abstract: The present invention provides a non-toxic diagnostic composition for intravaginal monitoring of vaginal infections. The present invention further provides a diagnostic article for intravaginal monitoring of vaginal infections with the article including an absorbent material for absorbing vaginal secretions and a composition suitable for identification of the pH or the buffer capacities associated with vaginal secretions. The diagnostic composition provides a visible indication of vaginal infections, such as bacterial vaginosis.
    Type: Application
    Filed: November 22, 2005
    Publication date: November 5, 2009
    Inventors: David Brusilovsky, Hadar Kessary-Shoam, Menashe Terem
  • Publication number: 20070134740
    Abstract: The present invention provides a bodily fluid-testing composition for the determination and quantification of a specific ion concentration exceeding a pre-set threshold in a tested fluid, in which an ion oppositely charged to the ion in the bodily fluid is used to compete with an indicator reagent in order to compensate for variability in specific binding of the bodily fluid ions. The present invention further provides an article for monitoring of bodily fluids comprising a substrate and an absorbent material for absorbing the bodily fluid. The substrate includes a composition suitable for identification of a specific ion concentration in a tested fluid. The article can be used to indicate the presence of abnormal ammonium concentration in human urine, amniotic fluid leakage, or biogenic secretions associated with bacterial vaginosis, parasite infections, or deficiency of lactobacillus population, without giving a false positive result.
    Type: Application
    Filed: September 28, 2006
    Publication date: June 14, 2007
    Inventors: David Brusilovsky, Menashe Terem, Adva Brand